It is a well established trend that Australian LPs are increasingly looking to internationalize their private equity exposure, arguably at the expense of domestic GPs. Foreign investors looking to enter Australia are not deterred. Sebastiaan van den Berg, managing director at HarbourVest Partners, has no plans to scale back, citing the country’s stable economy, rule of law and experienced GP community.
He does admit, however, that the retreat of domestic LPs leaves their foreign counterparts in a bind. "Perhaps from a more selfish perspective, less capital driving up valuations is better - to the extent...
Singapore sovereign wealth fund GIC Private saw its returns slow over the past year and warned the combination of high asset valuations, low interest rates and uncertain growth is likely to weigh on performance over at least the next decade.
India's Green House Ventures (GHV) Accelerator will partner with Japan and US-based early-stage investor World Innovation Labs (WiL) to launch a INR3.5 billion ($52 million) fund for investments in Indian start-ups.
KKR will exit India-based Gland Pharma as Shanghai Fosun Pharmaceutical acquires a majority stake in the business for up to $1.26 billion. KKR’s share of the proceeds will be $576.3 million, more than twice what it invested in Gland in 2014.
World Innovation Lab (WiL) has led a JPY1.1 billion ($10.6 million) investment in Japanese social media-oriented restaurant guide operator Retty.